Gland Pharma Limited (GLAND.NS)
INR 1764.95
(0.06%)
INR 1764.95
(0.06%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 7.72 Billion INR | -1.1% |
| 2022 | 7.81 Billion INR | -35.54% |
| 2021 | 12.11 Billion INR | 21.54% |
| 2020 | 9.96 Billion INR | 29.0% |
| 2019 | 7.72 Billion INR | 71.04% |
| 2018 | 4.51 Billion INR | 40.74% |
| 2017 | 3.21 Billion INR | -22.4% |
| 2016 | 4.13 Billion INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 1.43 Billion INR | -25.29% |
| 2024 Q2 | 1.63 Billion INR | 13.75% |
| 2023 FY | 7.72 Billion INR | -1.1% |
| 2023 Q2 | 1.94 Billion INR | -0.01% |
| 2023 Q3 | 1.91 Billion INR | -1.15% |
| 2023 Q1 | 1.94 Billion INR | 146.69% |
| 2023 Q4 | 1.92 Billion INR | 0.29% |
| 2022 Q1 | 2.29 Billion INR | -19.84% |
| 2022 FY | 7.81 Billion INR | -35.54% |
| 2022 Q4 | 786.83 Million INR | -66.08% |
| 2022 Q3 | 2.31 Billion INR | -3.85% |
| 2022 Q2 | 2.41 Billion INR | 5.27% |
| 2021 FY | 12.11 Billion INR | 21.54% |
| 2021 Q4 | 2.85 Billion INR | 4.71% |
| 2021 Q3 | 2.73 Billion INR | -9.62% |
| 2021 Q2 | 3.02 Billion INR | -13.85% |
| 2021 Q1 | 3.5 Billion INR | 34.65% |
| 2020 Q1 | 3.13 Billion INR | 60.99% |
| 2020 Q2 | 2.18 Billion INR | -30.21% |
| 2020 Q3 | 2.04 Billion INR | -6.74% |
| 2020 FY | 9.96 Billion INR | 29.0% |
| 2020 Q4 | 2.6 Billion INR | 27.58% |
| 2019 FY | 7.72 Billion INR | 71.04% |
| 2019 Q4 | 1.94 Billion INR | 26.41% |
| 2019 Q3 | 1.54 Billion INR | 0.0% |
| 2019 Q1 | 1.83 Billion INR | 0.0% |
| 2018 FY | 4.51 Billion INR | 40.74% |
| 2017 FY | 3.21 Billion INR | -22.4% |
| 2016 FY | 4.13 Billion INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Abbott India Limited | 12.01 Billion INR | 35.694% |
| Cipla Limited | 41.21 Billion INR | 81.258% |
| GlaxoSmithKline Pharmaceuticals Limited | 5.89 Billion INR | -30.934% |
| Kopran Limited | 509.56 Million INR | -1415.932% |
| Marksans Pharma Limited | 3.13 Billion INR | -146.242% |
| NGL Fine-Chem Limited | 413.16 Million INR | -1769.607% |
| Pfizer Limited | 5.51 Billion INR | -40.108% |
| Sanofi India Limited | 6.02 Billion INR | -28.124% |
| SMS Pharmaceuticals Limited | 498.26 Million INR | -1450.315% |
| TTK Healthcare Limited | 628.41 Million INR | -1129.212% |